Skip to main content
Fig. 3 | Trials

Fig. 3

From: Efficacy and safety of intramuscular administration of allogeneic adipose tissue derived and expanded mesenchymal stromal cells in diabetic patients with critical limb ischemia with no possibility of revascularization: study protocol for a randomized controlled double-blind phase II clinical trial (The NOMA Trial)

Fig. 3

MCB and WCB laboratories. Different laboratories have been assigned to the hospitals. MCB, master cell bank; WCB, working cell bank; NUC, Navarra University Hospital; SUH, Salamanca University Hospital; GMGUH, Gregorio Marañon General University Hospital; VAUCH, Virgen de la Arrixaca University Clinical Hospital; LFUH, La Fe University Hospital; VCUH, Valladolid Clinical University Hospital; LPUH, La Paz University Hospital; VE-CRH, Queen Victoria Eugenia-Cruz Roja Hospital; FJD, Jimenez Diaz Foundation University Hospital; HGUA, General University Hospital Alicante

Back to article page

Trials

ISSN: 1745-6215